SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-057345
Filing Date
2023-03-02
Accepted
2023-03-02 08:22:41
Documents
6
Effectiveness Date
2023-03-02

Document Format Files

Seq Description Document Type Size
1 S-8 d431797ds8.htm S-8 34190
2 EX-5.1 d431797dex51.htm EX-5.1 7839
3 EX-23.2 d431797dex232.htm EX-23.2 1583
4 EX-FILING FEES d431797dexfilingfees.htm EX-FILING FEES 14927
5 GRAPHIC g431797g44g31.jpg GRAPHIC 4875
6 GRAPHIC g431797g59q50.jpg GRAPHIC 1660
  Complete submission text file 0001193125-23-057345.txt   68900
Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340
Syros Pharmaceuticals, Inc. (Filer) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270209 | Film No.: 23696511
SIC: 2834 Pharmaceutical Preparations